What is Neotherapy?
Neotherapy operates at the intersection of cognitive science and digital health, providing a comprehensive suite of services designed to optimize mental performance and emotional regulation. The company utilizes advanced neurofeedback and bioregulation therapy to assist a diverse client base, ranging from individuals managing anxiety to children navigating the complexities of Autism Spectrum Disorder and ADHD. Beyond its clinical-grade therapeutic interventions, Neotherapy maintains a curated wellness store, creating a holistic ecosystem that supports long-term mental and physical health. By integrating remote video consultations with personalized brain training protocols, the company effectively bridges the gap between professional clinical support and accessible, home-based wellness solutions.
How much funding has Neotherapy raised?
Neotherapy has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
Key Investors in Neotherapy
PPP
Public-Private Partnership
What's next for Neotherapy?
With the recent infusion of capital, Neotherapy is poised to accelerate its operational growth and technological development. The strategic focus will likely shift toward expanding its digital infrastructure to accommodate a larger user base while refining its proprietary neurofeedback algorithms. As the company transitions through its current Series B/C stage, management is expected to prioritize market penetration and the diversification of its product offerings. By scaling its service delivery model, Neotherapy aims to capture a larger share of the burgeoning neuro-wellness sector, ultimately enhancing its ability to provide scalable, data-driven mental health interventions to a global audience.
See full Neotherapy company page
